Literature DB >> 23736003

Mesenchymal stem cells: a new trend for cell therapy.

Xin Wei1, Xue Yang, Zhi-peng Han, Fang-fang Qu, Li Shao, Yu-fang Shi.   

Abstract

Mesenchymal stem cells (MSCs), the major stem cells for cell therapy, have been used in the clinic for approximately 10 years. From animal models to clinical trials, MSCs have afforded promise in the treatment of numerous diseases, mainly tissue injury and immune disorders. In this review, we summarize the recent opinions on methods, timing and cell sources for MSC administration in clinical applications, and provide an overview of mechanisms that are significant in MSC-mediated therapies. Although MSCs for cell therapy have been shown to be safe and effective, there are still challenges that need to be tackled before their wide application in the clinic.

Entities:  

Mesh:

Year:  2013        PMID: 23736003      PMCID: PMC4002895          DOI: 10.1038/aps.2013.50

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  106 in total

1.  Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study.

Authors:  Marjolijn Duijvestein; Anne Christine W Vos; Helene Roelofs; Manon E Wildenberg; Barbara B Wendrich; Henricus W Verspaget; Engelina M C Kooy-Winkelaar; Frits Koning; Jaap Jan Zwaginga; Herma H Fidder; Auke P Verhaar; Willem E Fibbe; Gijs R van den Brink; Daniel W Hommes
Journal:  Gut       Date:  2010-10-04       Impact factor: 23.059

2.  Action at a distance: systemically administered adult stem/progenitor cells (MSCs) reduce inflammatory damage to the cornea without engraftment and primarily by secretion of TNF-α stimulated gene/protein 6.

Authors:  Gavin W Roddy; Joo Youn Oh; Ryang Hwa Lee; Thomas J Bartosh; Joni Ylostalo; Katie Coble; Robert H Rosa; Darwin J Prockop
Journal:  Stem Cells       Date:  2011-10       Impact factor: 6.277

3.  Effective treatment of severe steroid-resistant acute graft-versus-host disease with umbilical cord-derived mesenchymal stem cells.

Authors:  Kang-Hsi Wu; Chin-Kan Chan; Chris Tsai; Yu-Hsiang Chang; Martin Sieber; Tsan-Hung Chiu; Ming Ho; Ching-Tien Peng; Han-Ping Wu; Jing-Long Huang
Journal:  Transplantation       Date:  2011-06-27       Impact factor: 4.939

4.  Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes.

Authors:  Liang Peng; Dong-ying Xie; Bing-Liang Lin; Jing Liu; Hai-peng Zhu; Chan Xie; Yu-bao Zheng; Zhi-liang Gao
Journal:  Hepatology       Date:  2011-07-14       Impact factor: 17.425

5.  Nonhematopoietic/endothelial SSEA-1+ cells define the most primitive progenitors in the adult murine bone marrow mesenchymal compartment.

Authors:  Fernando Anjos-Afonso; Dominique Bonnet
Journal:  Blood       Date:  2006-09-26       Impact factor: 22.113

6.  Effects of inflammatory factors on mesenchymal stem cells and their role in the promotion of tumor angiogenesis in colon cancer.

Authors:  Yan Liu; Zhi-peng Han; Shan-shan Zhang; Ying-ying Jing; Xin-xin Bu; Chen-yang Wang; Kai Sun; Guo-cheng Jiang; Xue Zhao; Rong Li; Lu Gao; Qiu-dong Zhao; Meng-chao Wu; Li-xin Wei
Journal:  J Biol Chem       Date:  2011-05-18       Impact factor: 5.157

7.  Human mesenchymal stem cells modulate allogeneic immune cell responses.

Authors:  Sudeepta Aggarwal; Mark F Pittenger
Journal:  Blood       Date:  2004-10-19       Impact factor: 22.113

8.  Nanoparticulate cellular patches for cell-mediated tumoritropic delivery.

Authors:  Hao Cheng; Christian J Kastrup; Renuka Ramanathan; Daniel J Siegwart; Minglin Ma; Said R Bogatyrev; Qiaobing Xu; Kathryn A Whitehead; Robert Langer; Daniel G Anderson
Journal:  ACS Nano       Date:  2010-02-23       Impact factor: 15.881

9.  Cancer gene therapy using mesenchymal stem cells expressing interferon-beta in a mouse prostate cancer lung metastasis model.

Authors:  C Ren; S Kumar; D Chanda; L Kallman; J Chen; J D Mountz; S Ponnazhagan
Journal:  Gene Ther       Date:  2008-07-03       Impact factor: 5.250

10.  Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure.

Authors:  Biju Parekkadan; Daan van Poll; Kazuhiro Suganuma; Edward A Carter; François Berthiaume; Arno W Tilles; Martin L Yarmush
Journal:  PLoS One       Date:  2007-09-26       Impact factor: 3.240

View more
  306 in total

Review 1.  Targeting vascular and leukocyte communication in angiogenesis, inflammation and fibrosis.

Authors:  Johan Kreuger; Mia Phillipson
Journal:  Nat Rev Drug Discov       Date:  2015-11-27       Impact factor: 84.694

Review 2.  Cell-laden hydrogels for osteochondral and cartilage tissue engineering.

Authors:  Jingzhou Yang; Yu Shrike Zhang; Kan Yue; Ali Khademhosseini
Journal:  Acta Biomater       Date:  2017-01-11       Impact factor: 8.947

Review 3.  Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities.

Authors:  Ali Hassanzadeh; Heshu Sulaiman Rahman; Alexander Markov; Judi Januadi Endjun; Angelina Olegovna Zekiy; Max Stanley Chartrand; Nasrin Beheshtkhoo; Mohammad Amin Jadidi Kouhbanani; Faroogh Marofi; Marzieh Nikoo; Mostafa Jarahian
Journal:  Stem Cell Res Ther       Date:  2021-05-21       Impact factor: 6.832

Review 4.  Manufacturing Cell Therapies Using Engineered Biomaterials.

Authors:  Amr A Abdeen; Krishanu Saha
Journal:  Trends Biotechnol       Date:  2017-07-12       Impact factor: 19.536

5.  Progress and prospects in stem cell therapy and drug discovery.

Authors:  Qi Zhou
Journal:  Acta Pharmacol Sin       Date:  2013-06       Impact factor: 6.150

6.  Mesenchymal Stromal Cells Deficient in Autophagy Proteins Are Susceptible to Oxidative Injury and Mitochondrial Dysfunction.

Authors:  Sailaja Ghanta; Konstantin Tsoyi; Xiaoli Liu; Kiichi Nakahira; Bonna Ith; Anna A Coronata; Laura E Fredenburgh; Joshua A Englert; Claude A Piantadosi; Augustine M K Choi; Mark A Perrella
Journal:  Am J Respir Cell Mol Biol       Date:  2017-03       Impact factor: 6.914

7.  Comparable osteogenic capacity of mesenchymal stem or stromal cells derived from human amnion membrane and bone marrow.

Authors:  Mehran Ghasemzadeh; Ehteramolsadat Hosseini; Mohammadhossein Ahmadi; Maedeh Kamalizad; Naser Amirizadeh
Journal:  Cytotechnology       Date:  2018-01-05       Impact factor: 2.058

8.  Inhibitory effect and mechanism of mesenchymal stem cells on melanoma cells.

Authors:  J Zhang; L Hou; D Zhao; M Pan; Z Wang; H Hu; J He
Journal:  Clin Transl Oncol       Date:  2017-07-21       Impact factor: 3.405

Review 9.  Strategies to develop endogenous stem cell-recruiting bioactive materials for tissue repair and regeneration.

Authors:  Settimio Pacelli; Sayantani Basu; Jonathan Whitlow; Aparna Chakravarti; Francisca Acosta; Arushi Varshney; Saman Modaresi; Cory Berkland; Arghya Paul
Journal:  Adv Drug Deliv Rev       Date:  2017-07-19       Impact factor: 15.470

10.  Multipotent mesenchymal stromal cells are fully permissive for human cytomegalovirus infection.

Authors:  Guan-Hua Qiao; Fei Zhao; Shuang Cheng; Min-Hua Luo
Journal:  Virol Sin       Date:  2016-04-21       Impact factor: 4.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.